About the Product

Description


Ranfoli 750 Tablet containing Ranolazine is used for the management of chronic angina and related cardiovascular conditions. It helps improve exercise tolerance and supports better cardiac function in patients with angina.

Ranolazine works by improving the efficiency of energy utilization in heart muscle cells and helping reduce myocardial oxygen demand, thereby supporting normal cardiac performance and reducing angina-related symptoms.

The tablet is widely prescribed in cardiology practice for patients with chronic stable angina who require long-term anti-anginal therapy, leading to consistent prescription demand.

With the increasing prevalence of cardiovascular disorders and growing demand for effective heart care therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic efficacy, broad clinical relevance, and steady market demand make it a reliable product for growth in the cardiac care segment.

Some patients may experience dizziness, headache, nausea, constipation, weakness, or abdominal discomfort. Rarely, cardiac rhythm abnormalities, severe dizziness, fainting, or allergic reactions may occur and require immediate medical attention.

Ranfoli 750 Tablet is indicated for the treatment of chronic stable angina pectoris, particularly in patients who continue to experience symptoms despite conventional anti-anginal therapy. It helps reduce the frequency of angina episodes, improve exercise tolerance, and enhance quality of life.

This medicine should be used strictly under medical supervision. Use cautiously in patients with liver disease, kidney impairment, or a history of cardiac rhythm disorders. Ranolazine may interact with several medications, including certain antifungals, antibiotics, and heart medicines, so inform your healthcare professional about all ongoing treatments. Regular monitoring may be advised during therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions